This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abbott T.R. & Dhamdhere G. et al.: Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell, 181, 865–876 (2020)AbbottT.R. & DhamdhereG..:Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza.Cell,181,865–876(2020)Search in Google Scholar
Afkhami S., Yao Y., Xing Z.: Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Mol. Ther. Methods Clin. Dev. 3, 16030 (2016)AfkhamiS.YaoY.XingZ.:Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens.Mol. Ther. Methods Clin. Dev.3,16030(2016)Search in Google Scholar
Amitai G., Sorek R.: CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67 (2016)AmitaiG.SorekR.:CRISPR-Cas adaptation: insights into the mechanism of action.Nat. Rev. Microbiol.14,67(2016)Search in Google Scholar
Artika I.M., Wiyatno A., Ma’roef C.N.: Pathogenic viruses: Molecular detection and characterization. Infect. Genet. Evol. 81, 104215 (2020)ArtikaI.M.WiyatnoA.Ma’roefC.N.:Pathogenic viruses: Molecular detection and characterization.Infect. Genet. Evol.81,104215(2020)Search in Google Scholar
Barrangou R., Doudna J.A.: Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34, 933–941 (2016)BarrangouR.DoudnaJ.A.:Applications of CRISPR technologies in research and beyond.Nat. Biotechnol.34,933–941(2016)Search in Google Scholar
Bella R. & Kaminski R. et al.: Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. Mol. Ther Nucleic Acids, 12, 275–282 (2018)BellaR. & KaminskiR..:Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.Mol. Ther Nucleic Acids,12,275–282(2018)Search in Google Scholar
Bikard D., Hatoum-Aslan A., Mucida D., Marraffini L.A.: CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe, 12, 177–186 (2012)BikardD.Hatoum-AslanA.MucidaD.MarraffiniL.A.:CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.Cell Host Microbe,12,177–186(2012)Search in Google Scholar
Biti R., Ffrench R., Young J., Bennetts B., Stewart G., Liang T.: HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature med. 3, 252–253 (1997)BitiR.FfrenchR.YoungJ.BennettsB.StewartG.LiangT.:HIV-1 infection in an individual homozygous for the CCR5 deletion allele.Nature med.3,252–253(1997)Search in Google Scholar
Bowers N.L., Helton E.S., Huijbregts R.P., Goepfert P.A.., Heath S.L., Hel Z.: Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog. 10, e1003993 (2014)BowersN.L.HeltonE.S.HuijbregtsR.P.GoepfertP.A.HeathS.L.HelZ.:Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.PLoS Pathog.10,e1003993(2014)Search in Google Scholar
Broughton J.P., Deng X., Yu G., Fasching C.L., Servellita V., Singh J., Miao X., Streithorst J.A., Granados A., Sotomayor-Gonzalez A.: CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 38, 870–874 (2020)BroughtonJ.P.DengX.YuG.FaschingC.L.ServellitaV.SinghJ.MiaoX.StreithorstJ.A.GranadosA.Sotomayor-GonzalezA.:CRISPR-Cas12-based detection of SARS-CoV-2.Nat. Biotechnol.38,870–874(2020)Search in Google Scholar
Brouns S.J., Jore M.M., Lundgren M., Westra E.R., Slijkhuis R.J., Snijders A.P., Dickman M.J., Makarova K.S., Koonin E.V.: Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 321, 960–964 (2008)BrounsS.J.JoreM.M.LundgrenM.WestraE.R.SlijkhuisR.J.SnijdersA.P.DickmanM.J.MakarovaK.S.KooninE.V.:Small CRISPR RNAs guide antiviral defense in prokaryotes.Science,321,960–964(2008)Search in Google Scholar
Cassan E., Arigon-Chifolleau A.M., Mesnard J.M., Gross A., Gascuel O.: Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic. Proc. Natl. Acad. Sci. 113, 11537–11542 (2016)CassanE.Arigon-ChifolleauA.M.MesnardJ.M.GrossA.GascuelO.:Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic.Proc. Natl. Acad. Sci.113,11537–11542(2016)Search in Google Scholar
Ceasar S.A., Rajan V., Prykhozhij S.V., Berman J.N., Ignacimuthu S.: Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9. Biochem. Biophys. Acta, 1863, 2333–2344 (2016)CeasarS.A.RajanV.PrykhozhijS.V.BermanJ.N.IgnacimuthuS.:Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9.Biochem. Biophys. Acta,1863,2333–2344(2016)Search in Google Scholar
Center C.R.: Center for Systems Science and Engineering, Johns Hopkins Coronavirus Resource Center. COVID-19 Dashboard, https://coronavirus.jhu.edu/map.html (2022)CenterC.R.:Center for Systems Science and Engineering, Johns Hopkins Coronavirus Resource Center.COVID-19 Dashboard,https://coronavirus.jhu.edu/map.html(2022)Search in Google Scholar
Charpentier E., Marraffini L.A.: Harnessing CRISPR-Cas9 immunity for genetic engineering. Curr. Opin. Microbiol. 19, 114–119 (2014)CharpentierE.MarraffiniL.A.:Harnessing CRISPR-Cas9 immunity for genetic engineering.Curr. Opin. Microbiol.19,114–119(2014)Search in Google Scholar
Chaudhuri A., Halder K., Datta A.: Classification of CRISPR/Cas system and its application in tomato breeding. Theor. Appl. Genet. 135, 367–387 (2022)ChaudhuriA.HalderK.DattaA.:Classification of CRISPR/Cas system and its application in tomato breeding.Theor. Appl. Genet.135,367–387(2022)Search in Google Scholar
Chavez L., Calvanese V., Verdin E.: HIV latency is established directly and early in both resting and activated primary CD4 T cells. PLoS Pathog. 11, e1004955 (2015)ChavezL.CalvaneseV.VerdinE.:HIV latency is established directly and early in both resting and activated primary CD4 T cells.PLoS Pathog.11,e1004955(2015)Search in Google Scholar
Chen S., Yu X., Guo D.: CRISPR-Cas targeting of host genes as an antiviral strategy. Viruses, 10, 40 (2018)ChenS.YuX.GuoD.:CRISPR-Cas targeting of host genes as an antiviral strategy.Viruses,10,40(2018)Search in Google Scholar
Chen X., Rinsma M., Janssen J.M., Liu J., Maggio I., Gonçalves M.A.: Probing the impact of chromatin conformation on genome editing tools. Nucleic Acids Res. 44, 6482–6492 (2016)ChenX.RinsmaM.JanssenJ.M.LiuJ.MaggioI.GonçalvesM.A.:Probing the impact of chromatin conformation on genome editing tools.Nucleic Acids Res.44,6482–6492(2016)Search in Google Scholar
Cho S.W., Kim S., Kim J.M., Kim J.S.: Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230–232 (2013)ChoS.W.KimS.KimJ.M.KimJ.S.:Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.Nat. Biotechnol.31,230–232(2013)Search in Google Scholar
Chun T.W., Nickle D.C., Justement J.S., Meyers J.H., Roby G., Hallahan C.W., Kottilil S., Moir S., Mican J.M., Mullins J.I.: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714–720 (2008)ChunT.W.NickleD.C.JustementJ.S.MeyersJ.H.RobyG.HallahanC.W.KottililS.MoirS.MicanJ.M.MullinsJ.I.:Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.J. Infect. Dis.197,714–720(2008)Search in Google Scholar
Coen D.M., Schaffer P.A.: Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat. Rev. Drug Discov. 2, 278–288 (2003)CoenD.M.SchafferP.A.:Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets.Nat. Rev. Drug Discov.2,278–288(2003)Search in Google Scholar
Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F.: Acute HIV-1 infection. N. Engl. J. Med. 364, 1943–1954 (2011)CohenM.S.ShawG.M.McMichaelA.J.HaynesB.F.:Acute HIV-1 infection.N. Engl. J. Med.364,1943–1954(2011)Search in Google Scholar
Cui J., Li F., Shi Z.L.: Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181–192 (2019)CuiJ.LiF.ShiZ.L.:Origin and evolution of pathogenic coronaviruses.Nat. Rev. Microbiol.17,181–192(2019)Search in Google Scholar
De Wit E., Van Doremalen N., Falzarano D., Munster V.J.: SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523 (2016)De WitE.Van DoremalenN.FalzaranoD.MunsterV.J.:SARS and MERS: recent insights into emerging coronaviruses.Nat. Rev. Microbiol.14,523(2016)Search in Google Scholar
Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E.: CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 471, 602–607 (2011)DeltchevaE.ChylinskiK.SharmaC.M.GonzalesK.ChaoY.PirzadaZ.A.EckertM.R.VogelJ.CharpentierE.:CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.Nature,471,602–607(2011)Search in Google Scholar
Diner B.A., Lum K.K., Toettcher J.E., Cristea I.M.: Viral DNA sensors IFI16 and cyclic GMP-AMP synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during herpesvirus infection. MBio, 7, e01553 (2016)DinerB.A.LumK.K.ToettcherJ.E.CristeaI.M.:Viral DNA sensors IFI16 and cyclic GMP-AMP synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during herpesvirus infection.MBio,7,e01553(2016)Search in Google Scholar
Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R.: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, 1–9 (2000)DonoghueM.HsiehF.BaronasE.GodboutK.GosselinM.StaglianoN.DonovanM.WoolfB.RobisonK.JeyaseelanR.:A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.Circ. Res.87,1–9(2000)Search in Google Scholar
Doudna J.A., Charpentier E.: The new frontier of genome engineering with CRISPR-Cas9. Science, 346, 6213 (2014)DoudnaJ.A.CharpentierE.:The new frontier of genome engineering with CRISPR-Cas9.Science,346,6213(2014)Search in Google Scholar
Duan J., Lu G., Xie Z., Lou M., Luo J., Guo L., Zhang Y.: Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell res. 24, 1009–1012 (2014)DuanJ.LuG.XieZ.LouM.LuoJ.GuoL.ZhangY.:Genome-wide identification of CRISPR/Cas9 off-targets in human genome.Cell res.24,1009–1012(2014)Search in Google Scholar
Ebina H., Misawa N., Kanemura Y., Koyanagi Y.: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep. 3, 1–7 (2013)EbinaH.MisawaN.KanemuraY.KoyanagiY.:Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.Sci. Rep.3,1–7(2013)Search in Google Scholar
Ebrahimi S., Khanbabaei H., Abbasi S., Fani M., Soltani S., Zandi M., Najafimemar Z.: CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19. Avicenna J. Med. Biotechnol. 14, 3–9 (2022)EbrahimiS.KhanbabaeiH.AbbasiS.FaniM.SoltaniS.ZandiM.NajafimemarZ.:CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19.Avicenna J. Med. Biotechnol.14,3–9(2022)Search in Google Scholar
Eggleton J.S., Nagalli S.: Highly active antiretroviral therapy (HAART). StatPearls, 4 (2020)EggletonJ.S.NagalliS.:Highly active antiretroviral therapy (HAART).StatPearls,4(2020)Search in Google Scholar
Fätkenheuer G., Nelson M., Lazzarin A., Konourina I., Hoepelman A.I., Lampiris H., Hirschel B., Tebas P., Raffi F., Trottier B.: Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N. Engl. J. Med. 359, 1442–1455 (2008)FätkenheuerG.NelsonM.LazzarinA.KonourinaI.HoepelmanA.I.LampirisH.HirschelB.TebasP.RaffiF.TrottierB.:Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.N. Engl. J. Med.359,1442–1455(2008)Search in Google Scholar
Fehr A.R., Perlman S.: Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282, 1–23 (2015)FehrA.R.PerlmanS.:Coronaviruses: an overview of their replication and pathogenesis.Methods Mol. Biol.1282,1–23(2015)Search in Google Scholar
Fischer-Smith T., Croul S., Sverstiuk A.E., Capini C., L’Heureux D., Régulier E.G., Richardson M.W., Amini S., Morgello S., Khalili K.: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. NeuroVirology, 7, 528–541 (2001)Fischer-SmithT.CroulS.SverstiukA.E.CapiniC.L’HeureuxD.RégulierE.G.RichardsonM.W.AminiS.MorgelloS.KhaliliK.:CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.J. NeuroVirology,7,528–541(2001)Search in Google Scholar
Gallastegui E., Millán-Zambrano G., Terme J.M., Chávez S., Jordan A.: Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency. J. Virol. 85, 3187–3202 (2011)GallasteguiE.Millán-ZambranoG.TermeJ.M.ChávezS.JordanA.:Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.J. Virol.85,3187–3202(2011)Search in Google Scholar
Garneau J.E., Dupuis M.-È., Villion M., Romero D.A., Barrangou R., Boyaval P., Fremaux C., Horvath P., Magadán A.H., Moineau S.: The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67–71 (2010)GarneauJ.E.DupuisM.-È.VillionM.RomeroD.A.BarrangouR.BoyavalP.FremauxC.HorvathP.MagadánA.H.MoineauS.:The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.Nature,468,67–71(2010)Search in Google Scholar
Gasiunas G., Barrangou R., Horvath P., Siksnys V.: Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. 109, e2579 (2012)GasiunasG.BarrangouR.HorvathP.SiksnysV.:Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.Proc. Natl. Acad. Sci.109,e2579(2012)Search in Google Scholar
Gootenberg J.S., Abudayyeh O.O., Kellner M.J., Joung J., Collins J.J., Zhang F.: Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 360, 439–444 (2018)GootenbergJ.S.AbudayyehO.O.KellnerM.J.JoungJ.CollinsJ.J.ZhangF.:Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.Science,360,439–444(2018)Search in Google Scholar
Gootenberg J.S., Abudayyeh O.O., Lee J.W., Essletzbichler P., Dy A.J., Joung J., Verdine V., Donghia N., Daringer N.M., Freije C.A.: Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 356, 438–442 (2017)GootenbergJ.S.AbudayyehO.O.LeeJ.W.EssletzbichlerP.DyA.J.JoungJ.VerdineV.DonghiaN.DaringerN.M.FreijeC.A.:Nucleic acid detection with CRISPR-Cas13a/C2c2.Science,356,438–442(2017)Search in Google Scholar
Gorbalenya A.E. & Baker S.C. et al.: The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536 (2020)GorbalenyaA.E. & BakerS.C..:The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.Nat. Microbiol.5,536(2020)Search in Google Scholar
Griffin B.D., Verweij M.C., Wiertz E.J.: Herpesviruses and immunity: the art of evasion. Vet. Microbiol. 143, 89–100 (2010)GriffinB.D.VerweijM.C.WiertzE.J.:Herpesviruses and immunity: the art of evasion.Vet. Microbiol.143,89–100(2010)Search in Google Scholar
Guy J.L., Jackson R.M., Jensen H.A., Hooper N.M., Turner A.J.: Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS Lett. 272, 3512 (2005)GuyJ.L.JacksonR.M.JensenH.A.HooperN.M.TurnerA.J.:Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis.FEBS Lett.272,3512(2005)Search in Google Scholar
Heidenreich M., Zhang F.: Applications of CRISPR-Cas systems in neuroscience. Nat. Rev. Neurosci. 17, 36 (2016)HeidenreichM.ZhangF.:Applications of CRISPR-Cas systems in neuroscience.Nat. Rev. Neurosci.17,36(2016)Search in Google Scholar
Hladik F., McElrath M.J.: Setting the stage: host invasion by HIVNat. Rev. Immunol. 8, 447–457 (2008)HladikF.McElrathM.J.:Setting the stage: host invasion by HIVNat.Rev. Immunol.8,447–457(2008)Search in Google Scholar
Horlbeck M.A., Witkowsky L.B., Guglielmi B., Replogle J.M., Gilbert L.A., Villalta J.E., Torigoe S.E., Tjian R., Weissman J.S.: Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife, 5, e12677 (2016)HorlbeckM.A.WitkowskyL.B.GuglielmiB.ReplogleJ.M.GilbertL.A.VillaltaJ.E.TorigoeS.E.TjianR.WeissmanJ.S.:Nucleosomes impede Cas9 access to DNA in vivo and in vitro.Elife,5,e12677(2016)Search in Google Scholar
Hou P., Chen S., Wang S., Yu X., Chen Y., Jiang M., Zhuang K., Ho W., Hou W., Huang J.: Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci. Rep. 5, 1–12 (2015)HouP.ChenS.WangS.YuX.ChenY.JiangM.ZhuangK.HoW.HouW.HuangJ.:Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.Sci. Rep.5,1–12(2015)Search in Google Scholar
Hsu P.D., Lander E.S., Zhang F.: Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157, 1262–1278 (2014)HsuP.D.LanderE.S.ZhangF.:Development and applications of CRISPR-Cas9 for genome engineering.Cell,157,1262–1278(2014)Search in Google Scholar
Hu W., Kaminski R., Yang F., Zhang Y., Cosentino L., Li F., Luo B., Alvarez-Carbonell D., Garcia-Mesa Y., Karn J.: RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc. Natl. Acad. Sci. 111, 11461–11466 (2014)HuW.KaminskiR.YangF.ZhangY.CosentinoL.LiF.LuoB.Alvarez-CarbonellD.Garcia-MesaY.KarnJ.:RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.Proc. Natl. Acad. Sci.111,11461–11466(2014)Search in Google Scholar
Huang S.H. & Ren Y. et al.: Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J. Clin. Invest. 128, 876–889 (2018)HuangS.H. & RenY..:Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.J. Clin. Invest.128,876–889(2018)Search in Google Scholar
Hultquist J.F., Schumann K., Woo J.M., Manganaro L., McGregor M.J., Doudna J., Simon V., Krogan N.J., Marson A.: A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells. Cell rep. 17, 1438–1452 (2016)HultquistJ.F.SchumannK.WooJ.M.ManganaroL.McGregorM.J.DoudnaJ.SimonV.KroganN.J.MarsonA.:A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells.Cell rep.17,1438–1452(2016)Search in Google Scholar
Jiang F., Doudna J.A.: CRISPR/Cas9 structures and mechanisms. Annu. Rev. Biophys. 46, 505–529 (2017)JiangF.DoudnaJ.A.:CRISPR/Cas9 structures and mechanisms.Annu. Rev. Biophys.46,505–529(2017)Search in Google Scholar
Jiang W., Bikard D., Cox D., Zhang F., Marraffini L.A.: RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233–239 (2013)JiangW.BikardD.CoxD.ZhangF.MarraffiniL.A.:RNA-guided editing of bacterial genomes using CRISPR-Cas systems.Nat. Biotechnol.31,233–239(2013)Search in Google Scholar
Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E.: A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816–821 (2012)JinekM.ChylinskiK.FonfaraI.HauerM.DoudnaJ.A.CharpentierE.:A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity.Science,337,816–821(2012)Search in Google Scholar
Johnson K.E., Bottero V., Flaherty S., Dutta S., Singh V.V., Chandran B.: IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog, 10, e1004503 (2014)JohnsonK.E.BotteroV.FlahertyS.DuttaS.SinghV.V.ChandranB.:IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications.PLoS Pathog,10,e1004503(2014)Search in Google Scholar
Joyce M.G., Sankhala R.S., Chen W.H., Choe M., Bai, H., Hajduczki A., Yan L., Sterling S.L., Peterson C.E., Green E.C.: A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein. bioRxiv. 3, 15 (2020)JoyceM.G.SankhalaR.S.ChenW.H.ChoeM.BaiH.HajduczkiA.YanL.SterlingS.L.PetersonC.E.GreenE.C.:A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein.bioRxiv.3,15(2020)Search in Google Scholar
Kaminski R., Chen Y., Salkind J., Bella R., Young W.B., Ferrante P., Karn J., Malcolm T., Hu W., Khalili K.: Negative feedback regulation of HIV-1 by gene editing strategy. Sci. Rep. 6, 1–11 (2016)KaminskiR.ChenY.SalkindJ.BellaR.YoungW.B.FerranteP.KarnJ.MalcolmT.HuW.KhaliliK.:Negative feedback regulation of HIV-1 by gene editing strategy.Sci. Rep.6,1–11(2016)Search in Google Scholar
Kim S., Koo T., Jee H.G., Cho H.Y., Lee G., Lim D.G., Shin H.S., Kim J.S.: CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367–373 (2018)KimS.KooT.JeeH.G.ChoH.Y.LeeG.LimD.G.ShinH.S.KimJ.S.:CRISPR RNAs trigger innate immune responses in human cells.Genome Res.28,367–373(2018)Search in Google Scholar
Kimberland M.L., Hou W., Alfonso-Pecchio A., Wilson S., Rao Y., Zhang S., Lu Q.: Strategies for controlling CRISPR/ Cas9 off-target effects and biological variations in mammalian genome editing experiments. J. Biotechnol. 284, 91–101 (2018)KimberlandM.L.HouW.Alfonso-PecchioA.WilsonS.RaoY.ZhangS.LuQ.:Strategies for controlling CRISPR/ Cas9 off-target effects and biological variations in mammalian genome editing experiments.J. Biotechnol.284,91–101(2018)Search in Google Scholar
Konermann S., Lotfy P., Brideau N.J., Oki J., Shokhirev M.N., Hsu P.D.: Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell, 173, 665–676 (2018)KonermannS.LotfyP.BrideauN.J.OkiJ.ShokhirevM.N.HsuP.D.:Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors.Cell,173,665–676(2018)Search in Google Scholar
Kuba K., Imai Y., Ohto-Nakanishi T., Penninger J.M.: Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther. 128, 119–128 (2010)KubaK.ImaiY.Ohto-NakanishiT.PenningerJ.M.:Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters.Pharmacol. Ther.128,119–128(2010)Search in Google Scholar
Lebbink R.J., De Jong D.C., Wolters F., Kruse E.M., Van Ham P.M., Wiertz E.J., Nijhuis M.: A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci. Rep. 7, 1–10 (2017)LebbinkR.J.De JongD.C.WoltersF.KruseE.M.Van HamP.M.WiertzE.J.NijhuisM.:A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.Sci. Rep.7,1–10(2017)Search in Google Scholar
Lenasi T., Contreras X., Peterlin B.M.: Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell host microbe, 4, 123–133 (2008)LenasiT.ContrerasX.PeterlinB.M.:Transcriptional interference antagonizes proviral gene expression to promote HIV latency.Cell host microbe,4,123–133(2008)Search in Google Scholar
Li C., Guan X., Du T., Jin W., Wu B., Liu Y., Wang P., Hu B., Griffin G.E., Shattock R.J.: Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. J. Gen. Virol. 96, 2381–2393 (2015)LiC.GuanX.DuT.JinW.WuB.LiuY.WangP.HuB.GriffinG.E.ShattockR.J.:Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.J. Gen. Virol.96,2381–2393(2015)Search in Google Scholar
Liang C., Wainberg M.A., Das A.T., Berkhout B.: CRISPR/Cas9: a double-edged sword when used to combat HIV infection. Retrovirology, 13, 1–4 (2016)LiangC.WainbergM.A.DasA.T.BerkhoutB.:CRISPR/Cas9: a double-edged sword when used to combat HIV infection.Retrovirology,13,1–4(2016)Search in Google Scholar
Liao H.K., Gu Y., Diaz A., Marlett J., Takahashi Y., Li M., Suzuki K., Xu R., Hishida T., Chang C.J.: Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat. Commun. 6, 1–10 (2015)LiaoH.K.GuY.DiazA.MarlettJ.TakahashiY.LiM.SuzukiK.XuR.HishidaT.ChangC.J.:Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.Nat. Commun.6,1–10(2015)Search in Google Scholar
Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., Trilling M., Lu M., Dittmer U., Yang D.: Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J. Med. Virol. 92, 491–494 (2020)LiuJ.ZhengX.TongQ.LiW.WangB.SutterK.TrillingM.LuM.DittmerU.YangD.:Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.J. Med. Virol.92,491–494(2020)Search in Google Scholar
Liu M., Rehman S., Tang X., Gu K., Fan Q., Chen D., Ma W.: Methodologies for improving HDR efficiency. Front. Genet. 9, 691 (2019)LiuM.RehmanS.TangX.GuK.FanQ.ChenD.MaW.:Methodologies for improving HDR efficiency.Front. Genet.9,691(2019)Search in Google Scholar
Liu Z., Torresilla C., Xiao Y., Nguyen P.T., Caté C., Barbosa K., Rassart É., Cen S., Bourgault S., Barbeau B.: HIV-1 antisense protein of different clades induces autophagy and associates with the autophagy factor p62. J. Virol. 93, e01757 (2019)LiuZ.TorresillaC.XiaoY.NguyenP.T.CatéC.BarbosaK.RassartÉ.CenS.BourgaultS.BarbeauB.:HIV-1 antisense protein of different clades induces autophagy and associates with the autophagy factor p62.J. Virol.93,e01757(2019)Search in Google Scholar
Maeder M.L., Gersbach C.A.: Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430–446 (2016)MaederM.L.GersbachC.A.:Genome-editing technologies for gene and cell therapy.Mol. Ther.24,430–446(2016)Search in Google Scholar
Makarova K.S., Aravind L., Wolf Y.I., Koonin E.V.: Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct, 6, 1–27 (2011)MakarovaK.S.AravindL.WolfY.I.KooninE.V.:Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems.Biol. Direct,6,1–27(2011)Search in Google Scholar
Marraffini L.A., Sontheimer E.J.: Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature, 463, 568–571 (2010)MarraffiniL.A.SontheimerE.J.:Self versus non-self discrimination during CRISPR RNA-directed immunity.Nature,463,568–571(2010)Search in Google Scholar
Mei Y., Wang Y., Chen H., Sun Z.S., Ju X.D.: Recent progress in CRISPR/Cas9 technology. J. Genet. Genomics, 43, 63–75 (2016)MeiY.WangY.ChenH.SunZ.S.JuX.D.:Recent progress in CRISPR/Cas9 technology.J. Genet. Genomics,43,63–75(2016)Search in Google Scholar
Ming S., Tian-Rui X., Ce-Shi C.: The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models. Zool. Res. 37, 191 (2016)MingS.Tian-RuiX.Ce-ShiC.:The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.Zool. Res.37,191(2016)Search in Google Scholar
Mocarski E., Shenk T., Griffiths P.D., Pass R.: Cytomegaloviruses. Fields Virology: Sixth Edition, 1, 1960–2014 (2013)MocarskiE.ShenkT.GriffithsP.D.PassR.:Cytomegaloviruses.Fields Virology: Sixth Edition,1,1960–2014(2013)Search in Google Scholar
Nalawansha D.A., Samarasinghe K.T.: Double-barreled CRISPR technology as a novel treatment strategy for COVID-19. ACS Pharmacol. Transl. Sci. 3, 790–800 (2020)NalawanshaD.A.SamarasingheK.T.:Double-barreled CRISPR technology as a novel treatment strategy for COVID-19.ACS Pharmacol. Transl. Sci.3,790–800(2020)Search in Google Scholar
Narasipura S.D., Kim S., Al-Harthi L.: Epigenetic regulation of HIV-1 latency in astrocytes. J. Virol. 88, 3031–3038 (2014)NarasipuraS.D.KimS.Al-HarthiL.:Epigenetic regulation of HIV-1 latency in astrocytes.J. Virol.88,3031–3038(2014)Search in Google Scholar
Nath A.: Eradication of human immunodeficiency virus from brain reservoirs. J. NeuroVirology, 21, 227–234 (2015)NathA.:Eradication of human immunodeficiency virus from brain reservoirs.J. NeuroVirology,21,227–234(2015)Search in Google Scholar
Nguyen T.M., Zhang Y., Pandolfi P.P.: Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. Cell Res. 30, 189–190 (2020)NguyenT.M.ZhangY.PandolfiP.P.:Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.Cell Res.30,189–190(2020)Search in Google Scholar
Nicoll M.P., Proença J.T., Efstathiou S.: The molecular basis of herpes simplex virus latency. FEMS Microbiol. Rev. 36, 684–705 (2012)NicollM.P.ProençaJ.T.EfstathiouS.:The molecular basis of herpes simplex virus latency.FEMS Microbiol. Rev.36,684–705(2012)Search in Google Scholar
Nyamweya S., Hegedus A., Jaye A., Rowland-Jones S., Flanagan K.L., Macallan D.C.: Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Rev. Med. Virol. 23, 221–240 (2013)NyamweyaS.HegedusA.JayeA.Rowland-JonesS.FlanaganK.L.MacallanD.C.:Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.Rev. Med. Virol.23,221–240(2013)Search in Google Scholar
Panno S., Matić S., Tiberini A., Caruso A.G., Bella P., Torta L., Stassi R., Davino S.: Loop mediated isothermal amplification: principles and applications in plant virology. Plants, 9, 461 (2020)PannoS.MatićS.TiberiniA.CarusoA.G.BellaP.TortaL.StassiR.DavinoS.:Loop mediated isothermal amplification: principles and applications in plant virology.Plants,9,461(2020)Search in Google Scholar
Park R.J., Wang T., Koundakjian D., Hultquist J.F., Lamothe-Molina P., Monel B., Schumann K., Yu H., Krupzcak K.M., Garcia-Beltran W.: A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat. Genet. 49, 193–203 (2017)ParkR.J.WangT.KoundakjianD.HultquistJ.F.Lamothe-MolinaP.MonelB.SchumannK.YuH.KrupzcakK.M.Garcia-BeltranW.:A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.Nat. Genet.49,193–203(2017)Search in Google Scholar
Pearson T., Shultz L.D., Miller D., King M., Laning J., Fodor W., Cuthbert A., Burzenski L., Gott B., Lyons B.: Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγ null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin. Exp. Immunol. 154, 270–284 (2008)PearsonT.ShultzL.D.MillerD.KingM.LaningJ.FodorW.CuthbertA.BurzenskiL.GottB.LyonsB.:Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγ null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.Clin. Exp. Immunol.154,270–284(2008)Search in Google Scholar
Pellet P.E., Roizmann B.: Herpesviridae. Fields virology, 1, 1802–1822 (2013)PelletP.E.RoizmannB.:Herpesviridae.Fields virology,1,1802–1822(2013)Search in Google Scholar
Perlman S., Netland J.: Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439–450 (2009)PerlmanS.NetlandJ.:Coronaviruses post-SARS: update on replication and pathogenesis.Nat. Rev. Microbiol.7,439–450(2009)Search in Google Scholar
Rappuoli R.: Glycoconjugate vaccines: Principles and mechanisms Sci. Transl. Med. 10, 456 (2018)RappuoliR.:Glycoconjugate vaccines: Principles and mechanismsSci. Transl. Med.10,456(2018)Search in Google Scholar
Rauch J.N. & Valois E. et al.: A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material. J. Clin. Microbiol. 59, 4 (2021)RauchJ.N. & ValoisE..:A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material.J. Clin. Microbiol.59,4(2021)Search in Google Scholar
Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M.: Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 383, 45–51 (2004)RiceG.I.ThomasD.A.GrantP.J.TurnerA.J.HooperN.M.:Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.Biochem. J.383,45–51(2004)Search in Google Scholar
Roehm P., Shekarabi M., Wollebo H., Bellizzi A., He L., Salkind J., Khalili K.: Inhibition of HSV-1 replication by gene editing strategy. Sci. Rep. 6, 23146 (2016)RoehmP.ShekarabiM.WolleboH.BellizziA.HeL.SalkindJ.KhaliliK.:Inhibition of HSV-1 replication by gene editing strategy.Sci. Rep.6,23146(2016)Search in Google Scholar
Roizmann B., Knipe D.M., Whitley R.: Herpes simplex viruses. Fields virology, 1, 1823–1897 (2013)RoizmannB.KnipeD.M.WhitleyR.:Herpes simplex viruses.Fields virology,1,1823–1897(2013)Search in Google Scholar
Ruelas D.S., Chan J.K., Oh E., Heidersbach A.J., Hebbeler A.M., Chavez L., Verdin E., Rape M., Greene W.C.: MicroRNA-155 reinforces HIV latency. J. Biol. Chem. 290, 13736–13748 (2015)RuelasD.S.ChanJ.K.OhE.HeidersbachA.J.HebbelerA.M.ChavezL.VerdinE.RapeM.GreeneW.C.:MicroRNA-155 reinforces HIV latency.J. Biol. Chem.290,13736–13748(2015)Search in Google Scholar
Russell T.A., Stefanovic T., Tscharke D.C.: Engineering herpes simplex viruses by infection–transfection methods including recombination site targeting by CRISPR/Cas9 nucleases. J. Virol. Methods. 213, 18–25 (2015)RussellT.A.StefanovicT.TscharkeD.C.:Engineering herpes simplex viruses by infection–transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.J. Virol. Methods.213,18–25(2015)Search in Google Scholar
Safari F., Afarid M., Rastegari B., Haghighi A.B., Barekati-Mowahed M., Behbahani A.B.: CRISPR systems: Novel approaches for detection and combating COVID-19. Virus Res. 294, 198282 (2021)SafariF.AfaridM.RastegariB.HaghighiA.B.Barekati-MowahedM.BehbahaniA.B.:CRISPR systems: Novel approaches for detection and combating COVID-19.Virus Res.294,198282(2021)Search in Google Scholar
Siddell S.G., Walker P.J., Lefkowitz E.J., Mushegian A.R., Adams M.J., Dutilh B.E., Gorbalenya A.E., Harrach B., Harrison R.L., Junglen S.: Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses. Arch. Virol. 164, 943–946 (2019)SiddellS.G.WalkerP.J.LefkowitzE.J.MushegianA.R.AdamsM.J.DutilhB.E.GorbalenyaA.E.HarrachB.HarrisonR.L.JunglenS.:Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses.Arch. Virol.164,943–946(2019)Search in Google Scholar
Siliciano J.D., Kajdas J., Finzi D., Quinn T.C., Chadwick K., Margolick J.B., Kovacs C., Gange S.J., Siliciano R.F.: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature med. 9, 727–728 (2003)SilicianoJ.D.KajdasJ.FinziD.QuinnT.C.ChadwickK.MargolickJ.B.KovacsC.GangeS.J.SilicianoR.F.:Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.Nature med.9,727–728(2003)Search in Google Scholar
Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P.: Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. 101, 4240–4245 (2004)SimmonsG.ReevesJ.D.RennekampA.J.AmbergS.M.PieferA.J.BatesP.:Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.Proc. Natl. Acad. Sci.101,4240–4245(2004)Search in Google Scholar
Smith P.D., Meng G., Salazar-Gonzalez J.F., Shaw G.M.: Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol. 74, 642–649 (2003)SmithP.D.MengG.Salazar-GonzalezJ.F.ShawG.M.:Macrophage HIV-1 infection and the gastrointestinal tract reservoir.J. Leukoc. Biol.74,642–649(2003)Search in Google Scholar
Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C.: From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11, 59 (2019)SongZ.XuY.BaoL.ZhangL.YuP.QuY.ZhuH.ZhaoW.HanY.QinC.:From SARS to MERS, thrusting coronaviruses into the spotlight.Viruses,11,59(2019)Search in Google Scholar
Stern-Ginossar N., Weisburd B., Michalski A., Le V.T.K., Hein M.Y., Huang S.X., Ma M., Shen B., Qian S.B., Hengel H.: Decoding human cytomegalovirus. Science, 338, 1088–1093 (2012)Stern-GinossarN.WeisburdB.MichalskiA.LeV.T.K.HeinM.Y.HuangS.X.MaM.ShenB.QianS.B.HengelH.:Decoding human cytomegalovirus.Science,338,1088–1093(2012)Search in Google Scholar
Strong A., Musunuru K.: Genome editing in cardiovascular diseases. Nature Rev. Cardiol. 14, 11 (2017)StrongA.MusunuruK.:Genome editing in cardiovascular diseases.Nature Rev. Cardiol.14,11(2017)Search in Google Scholar
Su S., Wong G., Shi W., Liu J., Lai A.C., Zhou J., Liu W., Bi Y., Gao G.F.: Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends microbiol. 24, 490–502 (2016)SuS.WongG.ShiW.LiuJ.LaiA.C.ZhouJ.LiuW.BiY.GaoG.F.:Epidemiology, genetic recombination, and pathogenesis of coronaviruses.Trends microbiol.24,490–502(2016)Search in Google Scholar
Sunshine S. & Kirchner R. et al.: HIV integration site analysis of cellular models of HIV latency with a probe-enriched next-generation sequencing assay. J. Virol. 90, 4511–4519 (2016)SunshineS. & KirchnerR..:HIV integration site analysis of cellular models of HIV latency with a probe-enriched next-generation sequencing assay.J. Virol.90,4511–4519(2016)Search in Google Scholar
Tanaka P. & Santos J. et al.: A Crispr-Cas9 system designed to introduce point mutations into the human ACE2 gene to weaken the interaction of the ACE2 receptor with the SARS-CoV-2 S protein. Preprints.org. 1, 2020050134 (2020)TanakaP. & SantosJ..:A Crispr-Cas9 system designed to introduce point mutations into the human ACE2 gene to weaken the interaction of the ACE2 receptor with the SARS-CoV-2 S protein.Preprints.org.1,2020050134(2020)Search in Google Scholar
van Boheemen S. & de Graaf M. et al.: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio, 3, e00473 (2012)van BoheemenS. & de GraafM..:Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.MBio,3,e00473(2012)Search in Google Scholar
Van Der Oost J., Westra E.R., Jackson R.N., Wiedenheft B.: Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12, 479–492 (2014)Van Der OostJ.WestraE.R.JacksonR.N.WiedenheftB.:Unravelling the structural and mechanistic basis of CRISPR-Cas systems.Nat. Rev. Microbiol.12,479–492(2014)Search in Google Scholar
van Diemen F.R., Kruse E.M., Hooykaas M.J., Bruggeling C.E., Schürch A.C., van Ham P.M., Imhof S.M., Nijhuis M., Wiertz E.J., Lebbink R.J.: CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS pathog. 12, e1005701 (2016)van DiemenF.R.KruseE.M.HooykaasM.J.BruggelingC.E.SchürchA.C.van HamP.M.ImhofS.M.NijhuisM.WiertzE.J.LebbinkR.J.:CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections.PLoS pathog.12,e1005701(2016)Search in Google Scholar
van Diemen F.R., Lebbink R.J.: CRISPR/Cas9, a powerful tool to target human herpesviruses. Cell. Microbiol. 19, e12694 (2017)van DiemenF.R.LebbinkR.J.:CRISPR/Cas9, a powerful tool to target human herpesviruses.Cell. Microbiol.19,e12694(2017)Search in Google Scholar
Verheyen J. & Thielen A. et al.: Rapid rebound of a preexisting CXCR4-tropic human immunodeficiency virus variant after allogeneic transplantation with CCR5 Δ32 homozygous stem cells. Clin. Infect. Dis. 68, 684–687 (2019)VerheyenJ. & ThielenA..:Rapid rebound of a preexisting CXCR4-tropic human immunodeficiency virus variant after allogeneic transplantation with CCR5 Δ32 homozygous stem cells.Clin. Infect. Dis.68,684–687(2019)Search in Google Scholar
von Eije K.J., Ter Brake O., Berkhout B.: Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82, 2895–2903 (2008)von EijeK.J.Ter BrakeO.BerkhoutB.:Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference.J. Virol.82,2895–2903(2008)Search in Google Scholar
Wang D., Zhang F., Gao G.: CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell, 181, 136–150 (2020)WangD.ZhangF.GaoG.:CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors.Cell,181,136–150(2020)Search in Google Scholar
Wang G., Zhao N., Berkhout B., Das A.T.: CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Mol. Ther. 24, 522–526 (2016)WangG.ZhaoN.BerkhoutB.DasA.T.:CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape.Mol. Ther.24,522–526(2016)Search in Google Scholar
Wang H., La Russa M., Qi L.S.: CRISPR/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227–264 (2016)WangH.La RussaM.QiL.S.:CRISPR/Cas9 in genome editing and beyond.Annu. Rev. Biochem.85,227–264(2016)Search in Google Scholar
Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., Jiang C.: SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway. Cell res. 18, 290–301 (2008)WangH.YangP.LiuK.GuoF.ZhangY.ZhangG.JiangC.:SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway.Cell res.18,290–301(2008)Search in Google Scholar
Wang J., Quake S.R.: RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc. Natl. Acad. Sci. 111: 13157–13162 (2014)WangJ.QuakeS.R.:RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.Proc. Natl. Acad. Sci.111:13157–13162(2014)Search in Google Scholar
Wright A.V., Nuñez J.K., Doudna J.A.: Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell, 164, 29–44 (2016)WrightA.V.NuñezJ.K.DoudnaJ.A.:Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering.Cell,164,29–44(2016)Search in Google Scholar
Wu A. & Peng Y. et al.: Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host microbe, 27: 325–328 (2020)WuA. & PengY..:Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China.Cell host microbe,27:325–328(2020)Search in Google Scholar
Wu F. & Zhao S. et al.: A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269 (2020)WuF. & ZhaoS..:A new coronavirus associated with human respiratory disease in China.Nature,579,265–269(2020)Search in Google Scholar
Xiang X., Qian K., Zhang Z., Lin F., Xie Y., Liu Y., Yang Z.: CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia. J. Drug Target. 28, 727–731 (2020)XiangX.QianK.ZhangZ.LinF.XieY.LiuY.YangZ.:CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.J. Drug Target.28,727–731(2020)Search in Google Scholar
Xiong X., Chen M., Lim W.A., Zhao D., Qi L.S.: CRISPR/Cas9 for human genome engineering and disease research. Annu. Rev. Genomics Hum. Genet. 17, 131–154 (2016)XiongX.ChenM.LimW.A.ZhaoD.QiL.S.:CRISPR/Cas9 for human genome engineering and disease research.Annu. Rev. Genomics Hum. Genet.17,131–154(2016)Search in Google Scholar
Xu X., Fan S., Zhou J., Zhang, Y., Che Y., Cai, H., Wang L., Guo L., Liu L., Li Q.: The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of α-4 gene transcription. Virol. J. 13, 1–12 (2016)XuX.FanS.ZhouJ.ZhangY.CheY.CaiH.WangL.GuoL.LiuL.LiQ.:The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of α-4 gene transcription.Virol. J.13,1–12(2016)Search in Google Scholar
Yan W.X., Chong S., Zhang H., Makarova K.S., Koonin E.V., Cheng D.R., Scott D.A.: Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol. Cell, 70, 327–339 (2018)YanW.X.ChongS.ZhangH.MakarovaK.S.KooninE.V.ChengD.R.ScottD.A.:Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein.Mol. Cell,70,327–339(2018)Search in Google Scholar
Yang H., Gao P., Rajashankar K.R., Patel D.J.: PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell, 167, 1814–1828 (2016)YangH.GaoP.RajashankarK.R.PatelD.J.:PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease.Cell,167,1814–1828(2016)Search in Google Scholar
Yang H., Ren S., Yu S., Pan H., Li T., Ge S., Zhang J., Xia N.: Methods favoring homology-directed repair choice in response to CRISPR/Cas9 induced-double strand breaks. Int. J. Mol. Sci. 21, 6461 (2020)YangH.RenS.YuS.PanH.LiT.GeS.ZhangJ.XiaN.:Methods favoring homology-directed repair choice in response to CRISPR/Cas9 induced-double strand breaks.Int. J. Mol. Sci.21,6461(2020)Search in Google Scholar
Yuan M., Wu N.C., Zhu X., Lee C.C.D., So R.T., Lv H., Mok C.K., Wilson I.A.: A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science, 368, 630–633 (2020)YuanM.WuN.C.ZhuX.LeeC.C.D.SoR.T.LvH.MokC.K.WilsonI.A.:A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.Science,368,630–633(2020)Search in Google Scholar
Yuen K.S., Wang Z.M., Wong N.H.M., Zhang Z.Q., Cheng T.F., Lui W.Y., Chan C.P., Jin D.Y.: Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9. Virus res. 244, 296–303 (2018)YuenK.S.WangZ.M.WongN.H.M.ZhangZ.Q.ChengT.F.LuiW.Y.ChanC.P.JinD.Y.:Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.Virus res.244,296–303(2018)Search in Google Scholar
Zetsche B., Gootenberg J.S., Abudayyeh O.O., Slaymaker I.M., Makarova K.S., Essletzbichler P., Volz S.E., Joung J., Van Der Oost J., Regev A.: Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163, 759–771 (2015)ZetscheB.GootenbergJ.S.AbudayyehO.O.SlaymakerI.M.MakarovaK.S.EssletzbichlerP.VolzS.E.JoungJ.Van Der OostJ.RegevA.:Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.Cell,163,759–771(2015)Search in Google Scholar
Zhang F., Abudayyeh O.O., Gootenberg J.S.: A protocol for detection of COVID-19 using CRISPR diagnostics. Howard Hughes Medical Institute, 1, 1–8 (2020)ZhangF.AbudayyehO.O.GootenbergJ.S.:A protocol for detection of COVID-19 using CRISPR diagnostics.Howard Hughes Medical Institute,1,1–8(2020)Search in Google Scholar
Zhou P. & Yang X.L. et al.: Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv, doi: 10.1101/2020.01.22.914952 (2020)ZhouP. & YangX.L..:Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin.BioRxiv, DOI:10.1101/2020.01.22.914952(2020)Open DOISearch in Google Scholar
Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R.: A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 38, 727–733 (2020)ZhuN.ZhangD.WangW.LiX.YangB.SongJ.ZhaoX.HuangB.ShiW.LuR.:A novel coronavirus from patients with pneumonia in China, 2019.N. Engl. J. Med.38,727–733(2020)Search in Google Scholar
Zhu W., Lei R., Le Duff, Y., Li J., Guo F., Wainberg M.A., Liang C.: The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology, 12, 1–7 (2015)ZhuW.LeiR.Le DuffY.LiJ.GuoF.WainbergM.A.LiangC.:The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.Retrovirology,12,1–7(2015)Search in Google Scholar
Zhuang Q., Liu, S., Zhang X., Jiang W., Wang K., Wang S., Peng C., Hou G., Li J., Yu X.: Surveillance and taxonomic analysis of the coronavirus dominant in pigeons in China. Transbound. Emerg. Dis. 67, 1981–1990 (2020)ZhuangQ.LiuS.ZhangX.JiangW.WangK.WangS.PengC.HouG.LiJ.YuX.:Surveillance and taxonomic analysis of the coronavirus dominant in pigeons in China.Transbound. Emerg. Dis.67,1981–1990(2020)Search in Google Scholar
